FDA cleared launch ACIST recently secured FDA clearance and US launch for the ACIST Pro Diagnostic System, a variable-rate contrast management solution. Sales teams should target cardiovascular cath labs and radiology departments seeking precision and safety improvements in image-guided procedures.

Bracco synergy As part of the Bracco Group with global cath lab expertise, ACIST can leverage corporate backing for expanded sales channels, co-marketing opportunities, and inclusion into Bracco’s broader contrast media and imaging portfolios to drive cross-sell.

Expansion footprint With facilities in Silicon Valley, Maastricht, Shanghai, and Tokyo and a global direct employee base, there is potential for regional deployments, service expansion, and localized trainings to accelerate adoption in key markets.

Interventional focus ACIST’s leadership in rapid exchange FFR and high-definition IVUS positions it well to upsell to cardiovascular centers upgrading to advanced contrast imaging and guidance solutions, including radiology imaging workflows.

Partnership uplift Existing partnerships and distribution movements, such as with Medis and ORSIF collaborations, indicate receptivity to joint go-to-market programs, radiation safety education, and co-developed clinical demonstrations for sales engagement.